DFDVW vs JAZZ · rev $2.1M vs P/E 1988, rev $4.07B
DeFi Development Corp. Warrant (DFDVW) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
DeFi Development Corp. Warrant (DFDVW) common stock listed on NASDAQ.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported DFDVW revenue for 2024-12-31 was $2.1M. Net income was -$2.7M. Revenue was up 4.8% from 2023-12-31 to 2024-12-31. DFDVW currently screens at market cap $0.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
DFDVW currently screens at market cap $0. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the DFDVW and JAZZ stock pages for the full models.
Not investment advice.